| GO ID | GO:0001934 |
| Ontology | BP |
| GO Term | positive regulation of protein phosphorylation |
| Definition | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
3491 |
O00622 |
chr1: 85,580,761-85,583,962 |
|
CDK2AP1 |
cyclin-dependent kinase 2 associated protein 1 |
8099 |
O14519 |
chr12: 123,260,971-123,272,334 |
|
MUSK |
muscle, skeletal, receptor tyrosine kinase |
4593 |
O15146 |
chr9: 110,668,771-110,801,620 |
|
AXIN1 |
axin 1 |
8312 |
O15169 |
chr16: 287,440-352,673 |
|
HDAC3 |
histone deacetylase 3 |
8841 |
O15379 |
chr5: 141,620,876-141,636,870 |
|
TBX1 |
T-box 1 |
6899 |
O43435 |
chr22: 19,756,703-19,783,593 |
|
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
9475 |
O75116 |
chr2: 11,179,761-11,348,330 |
|
FLOT1 |
flotillin 1 |
10211 |
O75955 |
chr6: 30,727,709-30,742,733 |
|
FGF19 |
fibroblast growth factor 19 |
9965 |
O95750 |
chr11: 69,698,232-69,704,642 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
F2 |
coagulation factor II (thrombin) |
2147 |
P00734 |
chr11: 46,719,180-46,739,506 |
|
C3 |
complement component 3 |
718 |
P01024 |
chr19: 6,677,704-6,730,562 |
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog |
3845 |
P01116 |
chr12: 25,204,789-25,250,936 |
|
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
|
IGF2 |
insulin like growth factor 2 |
3481 |
P01344 |
chr11: 2,129,112-2,141,238 |
|
TNF |
tumor necrosis factor |
7124 |
P01375 |
chr6: 31,575,567-31,578,336 |
|
IL1B |
interleukin 1 beta |
3553 |
P01584 |
chr2: 112,829,751-112,836,903 |
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
2064 |
P04626 |
chr17: 39,687,914-39,730,426 |
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
4914 |
P04629 |
chr1: 156,815,640-156,881,850 |
|
ITGB3 |
integrin subunit beta 3 |
3690 |
P05106 |
chr17: 47,253,846-47,311,816 |
|
INSR |
insulin receptor |
3643 |
P06213 |
chr19: 7,112,255-7,294,034 |
|
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
|
ANXA2 |
annexin A2 |
302 |
P07355 |
chr15: 60,347,134-60,402,883 |
|
RAP2A |
RAP2A, member of RAS oncogene family |
5911 |
P10114 |
chr13: 97,434,222-97,469,128 |
|
RALB |
v-ral simian leukemia viral oncogene homolog B |
5899 |
P11234 |
chr2: 120,240,064-120,294,713 |
|
BMP2 |
bone morphogenetic protein 2 |
650 |
P12643 |
chr20: 6,767,664-6,780,280 |
|
BMP4 |
bone morphogenetic protein 4 |
652 |
P12644 |
chr14: 53,949,736-53,958,761 |
|
MMP9 |
matrix metallopeptidase 9 |
4318 |
P14780 |
chr20: 46,008,908-46,016,561 |
|
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
|
MT3 |
metallothionein 3 |
4504 |
P25713 |
chr16: 56,589,074-56,591,088 |
|
ACVR2A |
activin A receptor type IIA |
92 |
P27037 |
chr2: 147,844,517-147,930,826 |
|
MAPK3 |
mitogen-activated protein kinase 3 |
5595 |
P27361 |
chr16: 30,114,105-30,123,506 |
|
ERP29 |
endoplasmic reticulum protein 29 |
10961 |
P30040 |
chr12: 112,013,316-112,023,451 |
|
CCND2 |
cyclin D2 |
894 |
P30279 |
chr12: 4,273,772-4,305,350 |
|
CCND3 |
cyclin D3 |
896 |
P30281 |
chr6: 41,934,933-42,050,357 |
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
208 |
P31751 |
chr19: 40,230,317-40,285,536 |
|
FLT4 |
fms-related tyrosine kinase 4 |
2324 |
P35916 |
chr5: 180,601,506-180,649,624 |
|
OPRL1 |
opiate receptor-like 1 |
4987 |
P41146 |
chr20: 64,080,173-64,100,643 |
|
SOX9 |
SRY-box 9 |
6662 |
P48436 |
chr17: 72,121,020-72,126,420 |
|
CSNK1D |
casein kinase 1, delta |
1453 |
P48730 |
chr17: 82,239,023-82,273,731 |
|
EFNA5 |
ephrin-A5 |
1946 |
P52803 |
chr5: 107,376,889-107,670,895 |
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
5879 |
P63000 |
chr7: 6,374,523-6,403,977 |
|
RACK1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 |
10399 |
P63244 |
chr5: 181,236,909-181,248,096 |
|
ADAM17 |
ADAM metallopeptidase domain 17 |
6868 |
P78536 |
chr2: 9,488,486-9,555,792 |
|
DAB2 |
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
1601 |
P98082 |
chr5: 39,371,675-39,462,300 |
|
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
|
PLAUR |
plasminogen activator, urokinase receptor |
5329 |
Q03405 |
chr19: 43,646,095-43,670,547 |
|
PTK2 |
protein tyrosine kinase 2 |
5747 |
Q05397 |
chr8: 140,657,900-141,002,216 |
|
STK4 |
serine/threonine kinase 4 |
6789 |
Q13043 |
chr20: 44,966,474-45,079,959 |
|
SQSTM1 |
sequestosome 1 |
8878 |
Q13501 |
chr5: 179,806,398-179,838,078 |
|
RIPK1 |
receptor interacting serine/threonine kinase 1 |
8737 |
Q13546 |
chr6: 3,063,991-3,115,187 |
|
GAS6 |
growth arrest specific 6 |
2621 |
Q14393 |
chr13: 113,820,549-113,864,067 |
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2066 |
Q15303 |
chr2: 211,375,717-212,538,841 |
|
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
9370 |
Q15848 |
chr3: 186,842,690-186,858,463 |
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
4915 |
Q16620 |
chr9: 84,668,551-85,027,070 |
|
BRAT1 |
BRCA1-associated ATM activator 1 |
221927 |
Q6PJG6 |
chr7: 2,537,877-2,555,727 |
|
IL34 |
interleukin 34 |
146433 |
Q6ZMJ4 |
chr16: 70,579,895-70,660,682 |
|
KNDC1 |
kinase non-catalytic C-lobe domain (KIND) containing 1 |
85442 |
Q76NI1 |
chr10: 133,160,447-133,226,412 |
|
MAVS |
mitochondrial antiviral signaling protein |
57506 |
Q7Z434 |
chr20: 3,846,799-3,876,123 |
|
FLCN |
folliculin |
201163 |
Q8NFG4 |
chr17: 17,212,212-17,237,188 |
|
FBXO18 |
F-box protein, helicase, 18 |
84893 |
Q8NFZ0 |
chr10: 5,890,203-5,937,594 |
|
RB1CC1 |
RB1 inducible coiled-coil 1 |
9821 |
Q8TDY2 |
chr8: 52,622,456-52,745,843 |
|
FNIP1 |
folliculin interacting protein 1 |
96459 |
Q8TF40 |
chr5: 131,641,714-131,797,063 |
|
ITLN1 |
intelectin 1 (galactofuranose binding) |
55600 |
Q8WWA0 |
chr1: 160,876,539-160,885,170 |
|
MYDGF |
myeloid-derived growth factor |
56005 |
Q969H8 |
chr19: 4,641,374-4,670,370 |
|
GPER1 |
G protein-coupled estrogen receptor 1 |
2852 |
Q99527 |
chr7: 1,082,208-1,093,815 |
|
CIB1 |
calcium and integrin binding 1 |
10519 |
Q99828 |
chr15: 90,229,975-90,234,047 |
|
RARRES2 |
retinoic acid receptor responder (tazarotene induced) 2 |
5919 |
Q99969 |
chr7: 150,338,317-150,341,674 |
|
PINK1 |
PTEN induced putative kinase 1 |
65018 |
Q9BXM7 |
chr1: 20,633,455-20,651,511 |
|
FAM129A |
family with sequence similarity 129 member A |
116496 |
Q9BZQ8 |
chr1: 184,790,724-184,974,550 |
|
AKTIP |
AKT interacting protein |
64400 |
Q9H8T0 |
chr16: 53,491,040-53,504,411 |
|
PELI2 |
pellino E3 ubiquitin protein ligase family member 2 |
57161 |
Q9HAT8 |
chr14: 56,117,814-56,301,526 |
|
TNIK |
TRAF2 and NCK interacting kinase |
23043 |
Q9UKE5 |
chr3: 171,061,339-171,460,408 |